- Report
- August 2025
- 182 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- August 2025
- 185 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- January 2026
- 291 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 479 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 285 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 282 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 225 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 172 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 389 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 271 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- January 2026
- 193 Pages
Global
From €5195EUR$5,850USD£4,511GBP
- Report
- August 2025
- 185 Pages
Global
From €3498EUR$3,939USD£3,038GBP
- Report
- October 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,462GBP
- Report
- September 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,462GBP
- Report
- October 2025
- 150 Pages
Global
From €3419EUR$3,850USD£2,969GBP
€4307EUR$4,850USD£3,740GBP
- Report
- June 2025
- 285 Pages
Global
From €4436EUR$4,995USD£3,852GBP
- Report
- January 2026
- 86 Pages
Global
From €3500EUR$4,222USD£3,146GBP
- Report
- November 2025
- 160 Pages
Global
From €3508EUR$3,950USD£3,046GBP
- Training
- March 2025
- 2 Days
Global
From €1418EUR$1,597USD£1,231GBP
- Training
- November 2025
- 2 Days
Global
From €1596EUR$1,798USD£1,386GBP

Quality by Design (QbD) is a systematic approach to pharmaceutical manufacturing that focuses on product and process understanding, design, and control. It is based on the principles of risk management and quality assurance, and is intended to ensure that products meet their intended quality, safety, and efficacy requirements. QbD is a holistic approach to product development that involves the integration of product and process design, development, and control. It is a proactive approach to product development that seeks to identify and address potential risks before they become problems.
QbD is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that products are safe and effective. It also helps to reduce costs associated with product development and manufacturing, as well as improve product quality and consistency.
Some companies in the QbD market include Merck, Pfizer, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more